Aducanumab: A Deep Dive into BIIB037 and its Impact A compound, originally known as BIIB037, constitutes a notable endeavor to combat emerging Alzheimer's condition. Created by Biogen, aducanumab acts by targeting https://www.targetmol.com/compound/aducanumab